Yulin Ge Selected Research

Yulin Ge Research Topics

6	Multiple Sclerosis 01/2024 - 03/2009
3	Hypercapnia 12/2016 - 10/2014
2	Dementia (Dementias) 03/2024 - 01/2022
2	Atrophy 03/2024 - 12/2023
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 01/2022
2	Cognitive Dysfunction 01/2024 - 01/2022
2	Brain Diseases (Brain Disorder) 01/2022 - 03/2014
1	Disease Progression 01/2024
1	COVID-19 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Glioma (Gliomas) 04/2021
1	Vascular Remodeling 01/2021
1	Ischemia 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Hyperoxia 01/2017
1	Neuromyelitis Optica (Devic's Disease) 06/2016
1	Hypoxia (Hypoxemia) 03/2014
1	Diffuse Axonal Injury 09/2012
1	Brain Concussion (Cerebral Concussion) 07/2009
1	Relapsing-Remitting Multiple Sclerosis 06/2004

6	Oxygen (Dioxygen)IBA 03/2024 - 03/2012
3	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2022
3	Carbon DioxideIBA 12/2016 - 10/2014
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2021 - 01/2020
2	IronIBA 01/2019 - 03/2009
1	Ferrosoferric Oxide (Magnetite)FDA Link 12/2023
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2021
1	FibrinIBA 01/2021
1	A 7 (A-7)IBA 06/2016
1	Vasodilator Agents (Vasodilators)IBA 10/2014
1	Caffeine (No Doz)FDA LinkGeneric 03/2014
1	Indicators and Reagents (Reagents)IBA 09/2012
1	interleukin-24 (ST16)IBA 07/2009
1	Contrast MediaIBA 06/2004